Search

Author/Creator Lockhart, Donna

1. A randomised, double-blind, placebo-controlled, multicentre clinical trial of AZD1656 in diabetic patients hospitalised with COVID-19: The ARCADIA Trial - implications for therapeutic immune modulation. (September 2022)

Authors:
Chorlton, Jamie; Hollowood, Zoe; Dyer, Carlene; Lockhart, Donna; Boekman, Pascal; McCafferty, Kieran; Coffey, Pete; Marelli-Berg, Federica; Martin, John
Journal:
EClinicalMedicine
Issue:
Volume 51(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. ARCADIA study protocol: a phase II, randomised, double-blind, placebo-controlled clinical trial to assess the safety and efficacy of AZD1656 in patients with diabetes hospitalised with suspected or confirmed COVID-19. Issue 12 (1st December 2021)

Authors:
McCafferty, Kieran; Hollowood, Zoe; Allan, Michelle; Lockhart, Donna; Chorlton, Jamie; Martin, John
Journal:
BMJ open
Issue:
Volume 11:Issue 12(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO study. (February 2021)

Authors:
Katzenschlager, Regina; Poewe, Werner; Rascol, Olivier; Trenkwalder, Claudia; Deuschl, Günther; Chaudhuri, K Ray; Henriksen, Tove; van Laar, Teus; Lockhart, Donna; Staines, Harry; Lees, Andrew
Journal:
Parkinsonism & related disorders
Issue:
Volume 83(2021)
Page Start:
79
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗